⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Immunostimulant Market to Reach $288.82 billion, Globally, by 2034 at 9.9% CAGR: Allied Market Research
prnewswire.com
MRK
PFE
BNTX
BMY
AMGN
MRNA
Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb
globenewswire.com
MRK
BMY
INCY
AMGN
Sage Growth Partners Honored for Healthcare Marketing Campaign of the Year at 2025 PR Daily Awards
prnewswire.com
GEHC
PGNY
PGEN
BBY
KO
CMCSA
DIS
MRK
Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
prnewswire.com
MRK
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
businesswire.com
MRK
Ability Biotherapeutics nomme Angèle Maki, Ph. D., au poste de cheffe de la direction commerciale
businesswire.com
BMY
GENK
MRK
LLY
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
globenewswire.com
MRK
Senior Pharma and Biotech Leaders to Convene for Industry Forum at San Francisco CEO Ahead of JP Morgan Healthcare Conference
accessnewswire.com
JPM
JNJ
AMGN
MRK
BMY
REGN
Strategic Pharma Collaborations Propel RCC Market Growth
globenewswire.com
MRK
AZN
PFE
EXEL
BioNxt treibt „Melt in Your Mouth“-Cladribin-Formulierung voran, um die Behandlung von MS-Patienten mit Dysphagie zu verbessern
accessnewswire.com
MRK